Rinvoq

(upadacitinib)

24 HR upadacitinib 15 MG Extended Release Oral Tablet [Rinvoq]24 HR upadacitinib 30 MG Extended Release Oral Tablet [Rinvoq]

View 1 more

BLACK BOX WARNING

Dosage & administration

* Prior to treatment update immunizations and consider evaluating for active and latent tuberculosis, viral hepatitis, hepatic function, and pregnancy status

* Avoid initiation or interrupt RINVOQ if absolute lymphocyte count is less than 500 cells/mm3, absolute neutrophil count is less than 1000 cells/mm3, or hemoglobin level is less than 8 g/dL.

Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

* The recommended dosage is 15 mg once daily.

Atopic Dermatitis

* Pediatric Patients 12 Years of Age and Older Weighing at Least 40 kg and Adults Less Than 65 Years of Age: Initiate treatment with 15 mg orally once daily. If an adequate response is not achieved, consider increasing the dosage to 30 mg orally once daily.

* Adults 65 Years of Age and Older: Recommended dosage is 15 mg once daily.

* Severe Renal Impairment: Recommended dosage is 15 mg once daily.

Ulcerative Colitis

* Adults: The recommended induction dosage is 45 mg once daily for 8 weeks. The recommended maintenance dosage is 15 mg once daily. A maintenance dosage of 30 mg once daily may be considered for patients with refractory, severe, or extensive disease. Discontinue RINVOQ if adequate therapeutic response is not achieved with the 30 mg dosage. Use the lowest effective dosage needed to maintain response.

* See the Full Prescribing Information for the recommended dosage in patients with renal or hepatic impairment and for dosage modification due to drug interactions.

Most viewed Rinvoq resources

Coverage Authorization Appeal

Coverage Authorization Request

Complete Letter of Medical Necessity

Enroll in patient savings program

drug label

Rinvoq prescribing information

Have more Rinvoq questions?

Submit MSL Request

Learn More

Need to report a Rinvoq issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Rinvoq samples

Online Sample Form

Learn More

prior authorization

Rinvoq Prior authorization resources

Complete Letter of Medical Necessity

Coverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Coverage Authorization Appeal

Learn More

Benefits investigation

Rheumatology Enrollment Form

Gasteroenterology Enrollment Form

Dermatology Enrollment Form - Adults

Dermatology Enrollment Form - Adolescent

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Rinvoq Financial assistance options

Co-pay savings program

commercial only

Enroll in patient savings program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Enroll in Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Abbvie Patient Assistance Program Application - Online

Abbvie Patient Assistance Program Application - English

Abbvie Patient Assistance Program Application - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Rinvoq Patient education

Getting started on Rinvoq

NOT PROVIDED BY BRANDInstructions For Use - Psoriatic Arthritis

NOT PROVIDED BY BRANDInstructions For Use - Rheumatoid Arthritis

NOT PROVIDED BY BRANDInstructions For Use - Ankylosing Spondylitis

NOT PROVIDED BY BRANDIntructions For Use - Atopic Dermatitis (Adults)

NOT PROVIDED BY BRANDInstructions For Use - Atopic Dermatitis ( Adolescents)

NOT PROVIDED BY BRANDInstructions For Use - Ulcerative Colitis